Identification of Cuproptosis Clusters and Integrative Analyses in Parkinson’s Disease

Parkinson’s disease (PD) is the second most common neurodegenerative disease; it mainly occurs in the elderly population. Cuproptosis is a newly discovered form of regulated cell death involved in the progression of various diseases. Combining multiple GEO datasets, we analyzed the expression profile and immunity of cuproptosis-related genes (CRGs) in PD. Dysregulated CRGs and differential immune responses were identified between PD and non-PD substantia nigra. Two CRG clusters were defined in PD. Immune analysis suggested that CRG cluster 1 was characterized by a high immune response. The enrichment analysis showed that CRG cluster 1 was significantly enriched in immune activation pathways, such as the Notch pathway and the JAK-STAT pathway. KIAA0319, AGTR1, and SLC18A2 were selected as core genes based on the LASSO analysis. We built a nomogram that can predict the occurrence of PD based on the core genes. Further analysis found that the core genes were significantly correlated with tyrosine hydroxylase activity. This study systematically evaluated the relationship between cuproptosis and PD and established a predictive model for assessing the risk of cuproptosis subtypes and the outcome of PD patients. This study provides a new understanding of PD-related molecular mechanisms and provides new insights into the treatment of PD.

[1]  Yuepu Pu,et al.  Copper Induces Cognitive Impairment in Mice via Modulation of Cuproptosis and CREB Signaling , 2023, Nutrients.

[2]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[3]  Bilal Cakir,et al.  Dyslexia associated gene KIAA0319 regulates cell cycle during human neuroepithelial cell development , 2022, Frontiers in Cell and Developmental Biology.

[4]  Evan Z. Macosko,et al.  Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson’s disease , 2022, Nature Neuroscience.

[5]  K. Wakamatsu,et al.  Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase , 2022, International journal of molecular sciences.

[6]  G. Kroemer,et al.  Cuproptosis: a copper-triggered modality of mitochondrial cell death , 2022, Cell Research.

[7]  Scott J. Dixon,et al.  Copper-induced cell death , 2022, Science.

[8]  T. Golub,et al.  Copper induces cell death by targeting lipoylated TCA cycle proteins , 2022, Science.

[9]  N. Dzamko,et al.  Immune responses in the Parkinson's disease brain , 2022, Neurobiology of Disease.

[10]  A. Casini,et al.  Connecting copper and cancer: from transition metal signalling to metalloplasia , 2021, Nature Reviews Cancer.

[11]  A. Strafella,et al.  VMAT2 availability in Parkinson’s disease with probable REM sleep behaviour disorder , 2021, Molecular brain.

[12]  Xuezhong Li,et al.  Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson’s disease , 2021, Brain Research Bulletin.

[13]  Yuhu Zhang,et al.  Significant Difference of Immune Cell Fractions and Their Correlations With Differential Expression Genes in Parkinson’s Disease , 2021, Frontiers in Aging Neuroscience.

[14]  C. Vriend,et al.  Dietary Approaches to Improve Efficacy and Control Side Effects of Levodopa Therapy in Parkinson's Disease: A Systematic Review , 2021, Advances in nutrition.

[15]  D. Standaert,et al.  CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease , 2021, Brain : a journal of neurology.

[16]  Siguang Li,et al.  Immune Profiling of Parkinson’s Disease Revealed Its Association With a Subset of Infiltrating Cells and Signature Genes , 2021, Frontiers in Aging Neuroscience.

[17]  M. Greco,et al.  Copper Dependent Modulation of α-Synuclein Phosphorylation in Differentiated SHSY5Y Neuroblastoma Cells , 2021, International journal of molecular sciences.

[18]  E. Dardiotis,et al.  Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease , 2020, International journal of molecular sciences.

[19]  Qiong Zhang,et al.  Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response , 2020, Briefings Bioinform..

[20]  E. Hirsch,et al.  Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease , 2020, Movement disorders : official journal of the Movement Disorder Society.

[21]  F. C. Bennett,et al.  Immune cell regulation of glia during CNS injury and disease , 2020, Nature Reviews Neuroscience.

[22]  L. Bubacco,et al.  Copper Ions and Parkinson’s Disease: Why Is Homeostasis So Relevant? , 2020, Biomolecules.

[23]  R. Guillevin,et al.  Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson’s Disease , 2020, Cells.

[24]  K. Double,et al.  Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease , 2019, Aging cell.

[25]  M. Hayes Parkinson's Disease and Parkinsonism. , 2019, The American journal of medicine.

[26]  D. Richardson,et al.  The Role of the Antioxidant Response in Mitochondrial Dysfunction in Degenerative Diseases: Cross-Talk between Antioxidant Defense, Autophagy, and Apoptosis , 2019, Oxidative medicine and cellular longevity.

[27]  D. Jiao,et al.  Identification of Differentially Expressed Genes and Long Noncoding RNAs Associated with Parkinson's Disease , 2019, Parkinson's disease.

[28]  Kazuto Kobayashi,et al.  Human tyrosine hydroxylase in Parkinson’s disease and in related disorders , 2018, Journal of Neural Transmission.

[29]  L. Sanders,et al.  Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease , 2018, Neurobiology of Disease.

[30]  E. Benveniste,et al.  Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases. , 2016, Clinical immunology.

[31]  M. Okun,et al.  Diagnosing Parkinson Disease , 2016, Continuum.

[32]  D. Standaert,et al.  Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration , 2016, The Journal of Neuroscience.

[33]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[34]  A. Lang,et al.  Pharmacological treatment of Parkinson disease: a review. , 2014, JAMA.

[35]  D. Turnbull,et al.  Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?☆ , 2014, Ageing Research Reviews.

[36]  S. Rivera-Mancía,et al.  Copper and Copper Proteins in Parkinson's Disease , 2014, Oxidative medicine and cellular longevity.

[37]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[38]  B. Lai,et al.  Aging results in copper accumulations in glial fibrillary acidic protein‐positive cells in the subventricular zone , 2013, Aging cell.

[39]  Ya Hui Hung,et al.  Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis , 2013, Front. Aging Neurosci..

[40]  David N Hauser,et al.  Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism , 2013, Neurobiology of Disease.

[41]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[42]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[43]  Philip L De Jager,et al.  Parkinson's disease: genetics and pathogenesis. , 2011, Annual review of pathology.

[44]  Matthew D. Wilkerson,et al.  ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..

[45]  S. Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[46]  G. Raj,et al.  How to build and interpret a nomogram for cancer prognosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  D. Thiele,et al.  Mechanisms for copper acquisition, distribution and regulation. , 2008, Nature chemical biology.

[48]  I. Onyango Mitochondrial Dysfunction and Oxidative Stress in Parkinson’s Disease , 2008, Neurochemical Research.

[49]  Robert W. Taylor,et al.  High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease , 2006, Nature Genetics.

[50]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[51]  T. Montine,et al.  Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. , 1999, The American journal of pathology.

[52]  Ash A. Alizadeh,et al.  Profiling Tumor Infiltrating Immune Cells with CIBERSORT. , 2018, Methods in molecular biology.

[53]  Tanya Barrett,et al.  The Gene Expression Omnibus Database , 2016, Statistical Genomics.

[54]  Andrew E. Jaffe,et al.  Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .